Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
批准号:
332994
负责人:
Philip Anie
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-05-01 至 2016-05-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Arthritis commonly refers to several related conditions that affect joints, causing pain, inflammation and swelling and osteoarthritis is the most prevalent form. Osteoarthritis occurs when there is damage in and around the joints, which the body cannot r
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a novel anti-fibrotic peptide for the treatment of scleroderma
-
批准号:435913
-
项目类别:Operating Grants
-
资助金额:$59.07万
-
财政年份:2020
-
负责人:Philip Anie
-
依托单位:
Role of CD109 in regulating cellular signaling and responses in skin and oral squamous cell carcinoma cells
-
批准号:391152
-
项目类别:Operating Grants
-
资助金额:$78.3万
-
财政年份:2018
-
负责人:Philip Anie
-
依托单位:
Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
-
批准号:346651
-
项目类别:Operating Grants
-
资助金额:$45.95万
-
财政年份:2016
-
负责人:Philip Anie
-
依托单位:
Skin Repair, Regeneration and Restoration Research Group (SR4G)
-
批准号:289504
-
项目类别:Miscellaneous Programs
-
资助金额:$1.24万
-
财政年份:2013
-
负责人:Philip Anie
-
依托单位:
Regulation of TGF-beta action in chondrocytes: Role of ALK1-endoglin interplay
-
批准号:225735
-
项目类别:Operating Grants
-
资助金额:$18.47万
-
财政年份:2011
-
负责人:Philip Anie
-
依托单位:
Role of endoglin in aberrant TGF-beta signaling in scleroderma
-
批准号:221584
-
项目类别:Operating Grants
-
资助金额:$4.37万
-
财政年份:2010
-
负责人:Philip Anie
-
依托单位:
Identification of a low molecular weight peptide of CD109 as an anti-scarring agent
-
批准号:196281
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2009
-
负责人:Philip Anie
-
依托单位:
海外基金